Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Emerging Role of Gamma Delta T-cells in Immunotherapies - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Emerging Role of Gamma Delta T-cells in Immunotherapies" report has been added to Research and Markets' offering.

This edition of the Future Tech TOE focuses on the emerging role of gamma delta T-cell platforms in immunotherapy applications. This service provides valuable insights across the global adoptive T-cell therapy landscape, while outlining the key unmet needs across this space. Apart from profiling key innovators in this space, the research encompasses application overview, clinical trial analysis, summary of key technology drivers and challenges, IP overview, research funding scenario, and strategic insights across gamma delta T-cell platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

1. Overview

  • Emerging Role of T-cell-based Immunotherapies
  • Addressing Unmet Needs in Adoptive T-cell Therapies
  • T-cells are Likely to have Increasing Applications in Cancer Immunotherapy
  • Summary of Clinical Trials Involving T-cells

2. Innovation Tracker

  • Role of Gamma Delta T-cells in Immune Response Mediation
  • Next Generation T-cell Therapies
  • Applications of Gamma Delta T-cell Therapy in Oncology and Immunological Diseases
  • Novel Isolation Technique for Gamma Delta T-cells

3. Impact Analysis and Assessment

  • Overview of Key Technology Drivers and Restraints
  • Antigen Recognition Diversity Drives Increasing Applications of Gamma Delta T-cell-based Therapies
  • Leading Technological Restraints Include Sub-optimal Clinical Performance

4. IP Analysis and Strategic Insights

  • China Leads the Global IP Landscape for Gamma Delta T-cells
  • Allergy, Infectious Diseases and Cancer are Leading Research reason for Gamma Delta T-cells
  • Strategic Initiatives for Enhancing Gamma Delta T-cell Therapies

5. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 03/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.